Chengdu Zenitar Biomedical Technology Co., Ltd

This study is testing an oral drug called flonoltinib maleate for people with intermediate- or high-risk myelofibrosis, a serious bone marrow cancer, who have already tried and stopped responding to or could not tolerate standard JAK inhibitor drugs. About 64 participants will ta…

This early-stage study is testing a new oral medication called ZL-85FA in adults with advanced solid tumors, including certain breast, ovarian, and prostate cancers. The main goals are to check the drug's safety, how the body processes it, and to see if it can shrink or control t…